TG Therapeutics | TGTX - 资产



金融业
股票价格
USD
资产
USD 1.06B
现金及等价物
USD 199.51M
销售成本
USD 38.14M
流动资产
USD 630.76M
流动负债
USD 153.76M
债务
USD 245.34M
EBIT
USD 50.49M
EBITDA
USD 32.69M
员工
338
EPS每股收益
USD 0.14
股本和储备
USD 648.02M
销售毛利
USD 154.43M
债务利息支出
USD 6.53M
贷款资金
USD 245.65M
市值
USD 4.64B
净收入
USD 23.04M
营业费用
USD 142.08M
营业利润
USD 50.49M
普通股股本
USD 155.21M
PE价格收益
10.76
税前利润
USD 45.09M
销售收入
USD 192.57M
销售和管理费用
USD 50.73M
股票
USD 125.59M
贸易债权人
USD 61.64M
应收帐款人
USD 265.38M


资产 更改 日
AbbVie USD 133.96B 62M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Amgen USD 90.59B 445M 2025-12
Ardelyx USD 501.6M 15.43M 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Bayer EUR 104.54B 331M 2025-12
Biogen USD 29.44B 232M 2025-12
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Curis USD 29.23M 10.09M 2025-06
Gilead Sciences USD 59.02B 490M 2025-12
Infinity Pharmaceuticals USD 21.23M 8.72M 2023-06
J&J USD 199.21B 6.39B 2025-12
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Novartis USD 110.95B 3.66B 2025-12
Novavax USD 1.18B 3.38M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.06B 38.23M 2025-12
Verastem USD 176.85M 45.15M 2025-09
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12